Drug Shortage Report for AURO-TADALAFIL

Last updated on 2024-02-12 History
Report ID 199894
Drug Identification Number 02435926
Brand name AURO-TADALAFIL
Common or Proper name TADALAFIL
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 2 X 14
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-07-24
Estimated end date 2024-02-29
Actual end date
Shortage status Actual shortage
Updated date 2024-02-12
Company comments Replacement as 5mg 30 Btl
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2024-02-12 French Compare
v14 2024-02-12 English Compare
v13 2024-01-29 French Compare
v12 2024-01-29 English Compare
v11 2024-01-12 French Compare
v10 2024-01-12 English Compare
v9 2023-12-13 French Compare
v8 2023-12-13 English Compare
v7 2023-11-28 French Compare
v6 2023-11-28 English Compare
v5 2023-10-02 French Compare
v4 2023-10-02 English Compare
v3 2023-07-25 English Compare
v2 2023-07-24 French Compare
v1 2023-07-24 English Compare

Showing 1 to 15 of 15